Carnosine Supplementation Has No Effect on Inflammatory Markers in Adults with Prediabetes and Type 2 Diabetes: A Randomised Controlled Trial
Nutrients · 2024
DOI: 10.3390/nu16223900 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Saeede Saadati und 11 weiteren Autor:innen. Beteiligte Einrichtung: Monash Centre for Health Research and Implementation (MCHRI), Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC 3168,…. Hauptthemen laut MEDLINE: Carnosine, Diabetes Mellitus, Type 2, Prediabetic State, Dietary Supplements. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RACP, Royal Australasian College of Physicians (RACP), CASS foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: In vitro studies suggest that carnosine reduces inflammation by upregulating anti-inflammatory mediators and downregulating pro-inflammatory cytokines. However, human clinical trials examining the effects of carnosine on inflammatory biomarkers are scant. We conducted a secondary analysis of a double-blind randomised controlled trial (RCT) to examine the effects of carnosine supplementation on inflammatory markers and adipokines in participants with prediabetes or well-controlled type 2 diabetes (T2D).
Methods
Out of 88 participants who were recruited, 49 adults with prediabetes or well-controlled T2D (HbA1c: 6.6 ± 0.7% [mean ± SD]) who were treated with diet and/or metformin were eligible for inclusion. Participants were randomised to receive 2 g/day of carnosine or a matching placebo for 14 weeks. We measured serum concentrations of monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-6, IL-10, C-reactive protein (CRP), tumour necrosis factor-α (TNF-α), adiponectin, leptin, adipsin, serpin, and resistin levels at baseline and after 14 weeks. The trial was registered at clinicaltrials.gov (NCT02917928).
Results
Forty-one participants (M = 29/F = 12) aged 53 (42.6, 59.3) years [median (IQR)] completed the trial. After 14 weeks of supplementation, changes in pro- and anti-inflammatory cytokine and adipokine levels did not differ between the carnosine and placebo groups (p > 0.05 for all). The results remained unchanged after adjustment for confounders including age, sex, and anthropometric measures (e.g., body fat percentage and visceral adipose tissue).
Conclusions
In individuals with prediabetes and well-controlled T2D, carnosine supplementation did not result in any significant changes in inflammatory markers. Larger RCTs with longer follow-up durations are needed to evaluate whether carnosine may be beneficial in individuals with poorly controlled T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Monash Centre for Health Research and Implementation (MCHRI), Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC 3168, Australia.
- Australian Health Policy Collaboration, Institute for Health and Sport (IHES), Victoria University, Melbourne, VIC 8001, Australia.
- Cancer Aging and Vaccine Laboratory, School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC 3083, Australia.
- Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC 3220, Australia.
- Department of Pharmaceutical Sciences, University of Milan, 20133 Milan, Italy.
- School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC 3168, Australia.
ORCID-Profile: Saeede Saadati, Maximilian de Courten, Cyril Deceneux, Magdalena Plebanski, David Scott, Giancarlo Aldini, James Cameron, Aya Mousa, Barbora de Courten
Förderung
- RACP
- Royal Australasian College of Physicians (RACP)
- CASS foundation
- Monash International Tuition Scholarship (MITS)
- Monash Graduate Scholarship (MGS)
- Australian National Health and Medical Research Council (NHMRC)
- RMIT University Enabling Impact Platforms (EIP)
Zitieren
APA
Saadati, S., de Courten, M., Deceneux, C., Plebanski, M., Scott, D., Mesinovic, J., Jansons, P., Aldini, G., Cameron, J., Feehan, J., Mousa, A., & de Courten, B. (2024). Carnosine Supplementation Has No Effect on Inflammatory Markers in Adults with Prediabetes and Type 2 Diabetes: A Randomised Controlled Trial. Nutrients. https://doi.org/10.3390/nu16223900
Vancouver
Saadati S, de Courten M, Deceneux C, Plebanski M, Scott D, Mesinovic J, et al. Carnosine Supplementation Has No Effect on Inflammatory Markers in Adults with Prediabetes and Type 2 Diabetes: A Randomised Controlled Trial. Nutrients. 2024. doi:10.3390/nu16223900
BibTeX
@article{Saadati2024,
author = {Saadati, Saeede and de Courten, Maximilian and Deceneux, Cyril and Plebanski, Magdalena and Scott, David and Mesinovic, Jakub and Jansons, Paul and Aldini, Giancarlo and Cameron, James and Feehan, Jack and Mousa, Aya and de Courten, Barbora},
title = {Carnosine Supplementation Has No Effect on Inflammatory Markers in Adults with Prediabetes and Type 2 Diabetes: A Randomised Controlled Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16223900}
}
EUVIMED